Vibrio fischeri, a marine bacterium that forms a bioluminescent symbiosis with certain fish and squids, exhibits the unusual attribute of growth on 3':5'-cycic AMP (cAMP), apparently through the activity of a 3':5'-cyclic nucleotide phosphodiesterase (3':5'-CNP) with exceptionally high activity. The V. fischeri 3':5'-CNP is located in the periplasm, a novel cellular location for this enzyme in bacteria. To gain insight into the physiological function of this enzyme, we cloned the gene (designated cpdP) encoding it from V. fischeri This is the first bacterial 3':5'-CNP gene to be cloned. Sequencing and analysis of the 1.26-kb cpdP locus revealed a single open reading frame specifying a protein of 330 amino acid residues, including a 22-amino-acid leader peptide. The putative cpdP promoter contained a reasonable -10 promoter region (TATTAT) but contained no obvious -35 region; instead, a 12-bp inverted repeat (ITAAATATTTAA) occurred just upstream of this location. A possible rho-independent transcriptional terminator with a calculated free energy of -21.2 kcal. mol-1 (ca. -88.7 kJ-mol-1) followed the CpdP protein coding sequence. The predicted subunit molecular weight of 33,636 for the mature CpdP protein (36,087 less 2,451 for the leader peptide) was consistent with the molecular weight of 34,000 estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The deduced amino acid sequence of the CpdP protein exhibited 30.3% identity with that of the low-affinity 3':5'-CNP (PDE1) of Saccharomyces cerevisiae and 33.6% identity with that of the extracellular 3':5'-CNP ofDictyostelium discoideum. The residue identities clustered in two regions, residues 100 to 146 and 238 to 269, which contained 30 of the 33 amino acids conserved in all three proteins, 4 of which were histidines.
3':5'-Cyclic nucleotide phosphodiesterase (EC 3.1.4.17; 3':5'-CNP), which converts 3':5'-cyclic nucleotides (e.g., 3':5'-cyclic AMP [cAMP] and 3':5'-cyclic GMP [cGMP] ) to their corresponding 5'-nucleoside monophosphates, has been characterized extensively for eukaryotic organisms. The enzyme functions in a wide variety of signal-mediated cytoplasmic processes by modulating the levels of the secondary messenger 3':5'-cyclic nucleotides (5) . Besides cytoplasmic functions in eukaryotes, an extracellular form of the enzyme in cellular slime molds, such as Dictyostelium discoideum, hydrolyzes cAMP, which is involved in morphogenetic and aggregational signalling between cells (50) . The amino acid residue sequences have been obtained for several eukaryotic 3':5'-CNPs; nearly all contain a region of approximately 250 residues in which homology is present (15, 16, 29) . The exceptions, which lack the 250-residue region, are the low-affinity 3':5'-CNP (PDE1) of Saccharomyces cerevisiae (40, 49) and the extracellular 3':5'-CNP of D. discoideum (31) . The amino acid sequences of the S. cerevisiae (PDE1) and D. discoideum enzymes, however, exhibit substantial identity to each other, leading to the suggestion that they represent a second evolutionary lineage of eukaryotic 3':5'-CNPs (15, 40) .
Many species of prokaryotes also possess 3':5'-CNP; and apparently depends on the synthesis by V. fischeri of a novel periplasmic 3':5'-CNP (25) . The enzyme, which exhibits an exceptionally high specific activity (13, 25) , has been proposed to play a role in the species specificity of the fish and squid symbioses by protecting V. fischeri cells from possible toxic effects of host-released cAMP and by specifically permitting V. fischeri cells to utilize host-released cAMP as a growth substrate (25) . Alternatively, the enzyme may function in the scavenging of 3':5'-cyclic nucleotides in the marine environment (25) . In this report, we describe the cloning and sequence analysis of the gene, cpdP, for the periplasmic 3':5'-CNP from V. fischeri MJ-1 and the construction of a V. fischeri AcpdP mutant by gene replacement procedures. This is the first bacterial 3':5'-CNP gene to be cloned.
MATERIALS AND METHODS Bacterial strains, plasmids, and culture conditions. The strains used in this study are derivatives of E. coli K-12 and V. fischeri MJ-1 and are listed in Table 1 . For routine cultivation, the E. coli strains were grown on LB agar (52) and the V. fischeri strains were grown on LBS agar (20) , with the appropriate antibiotics (ampicillin, 80 jg. ml-1; chloramphenicol, 30 ,ug ml-'; kanamycin, 20 jg-ml-'; nalidixic acid, 20 jg. ml-'; neomycin, 200 ug ml-') for selection procedures. For selection and screening of strains for growth on cAMP, an E. coli minimal medium (ECM) and a V. fischen minimal medium (VFM) were used. ECM contained 50 mM NaCl, 1 mM MgSO4, 1 mM CaC12, 5 Fig. 1 ) and religated, thereby creating a 0.45-kb deletion within the cpdP coding region (pMER019). E. coli AG-1 transformed with pMER019 did not grow on minimal medium containing cAMP as the sole carbon, nitrogen, and phosphorus source and produced no detectable periplasmic 3':5'-CNP activity in assays with intact cells. To make the cpdP mutation selectable and thereby facilitate the isolation of a gene replacement mutant, we ligated the 1.3-kb neomycin resistance fragment of pUC4K (59) , excised with BamHI, to the BglII site of pMER019 to construct pMER213. E. coli S17-1 (53) was then transformed with pMER213 and mated to V. fischeri MJ-100 (Nxr) by a previously described procedure (24) . V. fischeri transconjugants were isolated and purified on LBS agar plates containing nalidixic acid and neomycin. The transconjugants were then screened for loss of resistance to chloramphenicol as an indication of loss of the vector, with retention of neomycin resistance as an indication of replacement of the wild-type cpdP gene with the cpdP deletion. Several apparently identical chloramphenicol-sensitive, neomycin-resistant strains were isolated by this procedure and, when tested for periplasmic 3':5'-CNP activity, were found to lack detectable activity. One of these mutants, designated MJ-301 (AcpdP::Nmr), was examined further.
For testing for complementation of the cpdP mutation in MJ-301 by the cpdP gene, pMER023 was conjugatively delivered from S17-1 to MJ-301, with transconjugant MJ-301(pMER023) being selected on LBS agar containing nalidixic acid and chloramphenicol. Growth was assayed for cells of MJ-301(pMER023) and of MJ-301 inoculated into VFM lacking NH4Cl and K2HPO4 and with cAMP or cGMP as the sole carbon and energy, nitrogen, and phosphorus source.
Determination of 3':5'-CNP activity. The procedure of Cheung (17) was used to assay for 3':5'-CNP activity in intact cells and periplasmic extracts as described previously (25) . (25); we hypothesized that the activity of this enzyme enables cells to grow on extracellular cAMP (25) . The periplasmic location of the enzyme and its possible involvement in the growth of V.
fischeri cells on cAMP were unexpected; in bacteria, the enzyme is generally considered as functioning either to protect cells from the deleterious effects of high cytoplasmic levels of cAMP or to modulate the expression of cAMPcontrolled genes by regulating cytoplasmic levels of cAMP (2, 9) . Because (2, 45) , and from the cloned gene (cpdB) encoding the periplasmic 2':3'-cyclic nucleotide phosphodiesterase:3'-nucleotidase of E. coli (4, 34) . To our knowledge, cpdP is the first bacterial 3':5'-CNP gene to be cloned.
Subcloning and deletion analysis of the V. fischeri cpdP locus. For definition of the portion of the 12 kb of V. fischeri DNA in pMER120 that specified the cpdP region, pMER120 was subjected to subcloning and exonuclease III deletion analysis (see Materials and Methods). First, restriction endonuclease cleavage sites found within the cloned DNA were used to cut it into smaller fragments, which were then ligated to appropriate sites in various vectors (Fig. 1 ). E. coli AG-1 was transformed with the resulting vectors, and the transformants were screened for their ability to grow on cAMP and synthesize periplasmic 3':5'-CNP (Fig. 1 ). This procedure localized the cpdP region to a 2.3-kb BamHINcoI fragment of DNA (pMER026). Next, exonuclease III digestion of the insert DNA in pMER026, unidirectionally from the left and then, with the resulting vector (pMER017), unidirectionally from the right, was used to resolve more finely the cpdP locus (Fig. 1) . As described above, cells of E. coli AG-1 were transformed with the resulting vectors, and the transformants were screened for growth on cAMP and synthesis of periplasmic 3':5'-CNP. This process defined the cpdP locus to a 1.26-kb fragment of V. fischeri DNA (pMER013). In showing a one-to-one correlation between 3':5'-CNP activity and growth on cAMP (Fig. 1) , the subcloning and exonuclease III digestion procedures demonstrated that the 1.26-kb cpdP locus of the V. A putative promoter region upstream of the cpdP coding region was identified by visual inspection of the DNA sequence. Nucleotides 95 to 100 (TATTAT) conform reasonably well to typical -10 promoter sequences recognized by E. coli RNA polymerases (42) , whereas a -35 promoter sequence apparently is absent (Fig. 2) . Just upstream of the region at which a -35 hexanucleotide would be expected, however, a 12-bp inverted repeat (TTAAATAT'ITAA) was found (nucleotides 60 to 71). The V. fischeri MJ-1 luminescence (lu) operon promoter also lacks a canonical -35 region; a 20-bp inverted repeat adjacent to this site is the putative binding site for the LuxR protein, the lux transcriptional activator (see reference 36 for a review). A putative Shine-Dalgarno ribosome binding site (AAGG) occurs 6 bases upstream of the ATG translation initiation codon (51) . This sequence and its location upstream of the ATG codon agree reasonably well with the preferred spacing and nucleotide sequence of ribosome binding sites in E. coli genes (27) . A possible stem-loop structure consisting of a 12-base stem and an 8-base loop and followed by a poly-T region was identified 13 bp downstream of the TAA stop codon (Fig. 2) . This structure could serve as a rho factor-independent transcriptional terminator; its calculated free energy is -21 (31) . The boxes highlight amino acid residue identities. Regions of identity for the three sequences cluster in two areas, from residues 100 to 146 and residues 238 to 269 of the V. fischeri sequence.
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leader peptidase predicted to be between residue 22 (S) and residue 23 (G) (Fig. 2) . Cleavage between these two residues was confirmed by Edman degradation microsequence analysis of the first 20 amino-terminal residues of the mature protein, which was purified from periplasm contents of V.
fischeri MJ-1 (13) . The sequence, beginning with the aminoterminal residue, was found to be X-(
Thus, the first 20 amino acid residues of the mature protein matched those of the deduced sequence following the proposed pro-CpdP leader peptide (residues 23 to 42; Fig. 2 ), except that a definite assignment could not be made for the first residue, X, because of the presence of contaminating free amino acids in the sample (G, S. A, M, and K were detected). Residues 2 (S), 10 (S), and 16 (D) were considered probable but tentative assignments because of the lower yields of these residues. The deduced monomeric molecular weight of the mature protein was calculated to be 33,636 (36,087 less 2,451 for the leader peptide), similar to the value of 34,000 estimated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the purified protein (13) . The pI of the mature protein was calculated to be 5. 49. Comparison of the deduced amino acid sequence for the V. fischeri CpdP protein with those for other proteins. We compared the deduced amino acid sequence for the V.
fischeri pro-CpdP protein with sequences available in the Swiss-Prot protein sequence data base (see Materials and Methods). In this analysis, alignments were optimized and we considered statistically significant those sequences with identity scores more than 10 standard deviations above the mean score of random permutation. Only two proteins, both 3':5'-CNPs, scored at this level; both had standard deviation scores at least twice that of the next most similar protein. One, the low-affinity 3':5'-CNP (PDE1) of the yeast S. cerevisiae (40) , exhibited 30.3% identity to the V. fischeri sequence, and the other, the precursor polypeptide of the extracellular 3':5'-CNP of the slime mold D. discoideum (31) , exhibited 33.6% amino acid residue identity. A multiple alignment of the three sequences is shown in Fig. 3 . The gaps necessary for optimal alignment presumably reflect in part the phylogenetic differences among the three organisms as well as differences in the structural and functional aspects of the three enzymes. The substantial sequence similarity between the two eukaryotic 3':5'-CNPs was described previously (40) . We noted, moreover, that the amino acid residue identities for the three proteins clustered in two regions, residues 100 to 146 and residues 238 to 269 of the V. fischeri sequence (Fig. 3) . These regions contained 30 of the 33 amino acids conserved in all three proteins. Furthermore, histidine, which is present at only six positions in the V. among the cpdP gene, periplasmic 3':5'-CNP activity, and growth of cells on cAMP, we next constructed and examined a AcpdP mutant, MJ-301 (AcpdP::Nmr). To construct this mutant, we replaced by marker exchange procedures (24) the wild-type cpdP gene with a 0.45-kb BglII cpdP deletion.
To facilitate the isolation of recombinant strains, we had subcloned into the cpdP deletion a gene encoding neomycin resistance (see Materials and Methods). MJ-301, which produced no periplasmic 3':5'-CNP activity, did not grow in VFM broth containing cAMP as the sole carbon and energy source (with or without NH4Cl and K2HPO4), but it grew well in VFM broth containing glucose ( Table 2 ). The introduction of pMER023 (cpdP+) into MJ-301 enabled this strain to grow on cAMP, thereby demonstrating that the mutation in cpdP could be genetically complemented. These results, in demonstrating that the cpdP gene is both necessary and sufficient for V. fischeri cells to grow on cAMP, confirm the relationship among the cpdP gene, the synthesis of periplasmic 3':5'-CNP, and the ability of V. fischeri to grow on cAMP. Furthermore, they demonstrate that cpdP is not a gene essential for the survival and growth of V. fischeri.
In an earlier study (25) , we had demonstrated that the partially purified enzyme attacked only cAMP and cGMP of the substrates tested. Besides not growing on cAMP, MJ-301 also did not grow on cGMP whereas, like MJ-1, it grew on all the other nucleotides tested as sole carbon and energy sources ( Table 2 ). The lack of growth of MJ-301 on cAMP and cGMP is consistent with our earlier data on the enzyme and affirms our previous conclusions that the enzyme exhibits specificity for 3':5'-cycic nucleotide substrates and does not function as a nonspecific phosphatase. As with cAMP, MJ-301 regained the ability to grow on cGMP when it contained pMER023 (cpdP+) ( Table 2 ).
The periplasmic 3':5'-CNP of V. fischeri could have additional functions besides permitting cells to grow on 3':5'-cyclic nucleotides, such as defense against extracellular cAMP (25) . We therefore tested the effects of high concentrations of extracellular cAMP on the growth characteristics and luminescence of V. fischeri MJ-301. Many cellular growth activities in enteric bacteria are controlled by cAMP (8) , and cAMP is a primary activator of lux gene transcription in V. fischeri (see reference 36 for a review). We reasoned, therefore, that if extracellular cAMP were toxic for V. flscheri and if the periplasmic 3':5'-CNP functioned to protect V. fischeri from that toxic effect by degrading the cAMP, then cells of MJ-301, which lack the enzyme, would exhibit altered growth and luminescence characteristics when exposed to high concentrations of cAMP in the medium. However, regardless of the presence or amount of cAMP added to the medium (LBS broth with no added cAMP, 5 mM cAMP, or 10 mM cAMP), MJ-301 grew at a rate and to a final cell density like M-1 and produced light and regulated light production like MJ-1. Similar results were obtained with cells tested in VFM broth. The lack of obvious effects on growth or luminescence suggests that extracellular cAMP is not toxic for V. fischeri. Consequently, it is unlikely, at least under the conditions considered here, that the periplasmic 3':5'-CNP of V. fischeri is necessary for defense against extracellular cAMP.
DISCUSSION
The synthesis of a periplasmic 3':5'-CNP accounts for the unusual ability of V. fischeri, a common marine bacterium, to grow on cAMP as a sole source of carbon and energy, nitrogen, and phosphorus. The novel periplasmic location of the enzyme and its exceptionally high specific activity (25) suggested that the enzyme might be involved in the growth of V. fischeri cells on cAMP. This possible relationship provided a strategy by which the gene (cpdP) for this enzyme was successfully cloned in E. coli. Mutagenesis of the gene and use of gene replacement procedures to construct a cpdP mutant of V. fischeri permitted the relationship between the enzyme and growth on cAMP to be confirmed.
Cloning of the cpdP gene through selection for growth of E. coli cells on cAMP also confirmed an earlier conclusion that for growth on 3':5'-cyclic nucleotides, most enteric bacteria would require only one new enzyme, periplasmic 3':5'-CNP (25) . E. coli and many other enteric bacteria synthesize a periplasmic (membrane-associated) 5'-nucleotidase that permits cells to dephosphorylate 5'-AMP from the environment to adenosine (e.g., 6, 7, 37, 46, 62) , which can then be transported across the cytoplasmic membrane and catabolized for growth (39, 62) . Exceptions to this single new enzyme idea would be certain strains of S. typhimurium that lack 5'-nucleotidase activity (38) .
Isolation of the cpdP gene through selection for growth on cAMP was successful when the selection medium lacked nitrogen and phosphorus. We had noted that the presence of nitrogen and phosphorus can suppress the growth of V. fischeri on cAMP under some conditions (21) ; this suppression might be more severe in E. coli. The growth suppression, however, apparently is not due to inhibition of the activity of 3':5'-CNP by phosphate or nitrogen, since the presence of neither 0.25 mM KH2PO4 nor 15 mM NH4Cl decreases the activity of the purified enzyme (13) . Other possibilities include repression of the synthesis of 3':5'-CNP or effects on 5'-nucleotidase and the adenosine uptake system. Regardless of this issue, E. coli containing the cpdP gene, like V. fischeri, can utilize 3':5'-cyclic nucleotides as its sole source of carbon and energy, nitrogen, and phosphorus for growth.
The rapid growth on cAMP of E. coli containing the V. fischeri cpdP gene, besides indicating that the cpdP gene is expressed properly and that the CpdP protein functions appropriately in the environment of the E. coli periplasm, suggests that the E. coli protein secretory apparatus recognizes and properly processes the V. fischeri pro-CpdP leader peptide. Analysis of the pro-CpdP leader peptide sequence VOL. 175, 1993 on January 12, 2018 by guest http://jb.asm.org/ Downloaded from (Fig. 2 ) supports this suggestion in that the sequence exhibits features typical of leader peptides of E. coli and other bacteria (19, 41, 60) . The description given here is, to our knowledge, the first report of an exported protein and a leader peptide in V. fischeri.
Beacham and coworkers (4, 34) cloned from E. coli and sequenced a different periplasmic cyclic nucleotide phosphodiesterase gene, cpdB, which encodes a 2':3'-cyclic nucleotide phosphodiesterase:3'-nucleotidase. The periplasmic V. fischeri 3':5'-CNP differs from that enzyme in substrate specificity (25) and in other biochemical attributes (13) . However, V. fischeri does synthesize a periplasmic 2':3'-cyclic nucleotide phosphodiesterase:3'-nucleotidase, since it grows readily on 2':3'-cAMP (25; Table 2 ). That AcpdP mutant MJ-301, like parent strain MJ-1, grows on 2':3'-cAMP and on 3'-AMP but, in contrast to MJ-1, has lost the ability to grow on 3':5'-cyclic nucleotides (Table 2 ) further strengthens our conclusion that periplasmic 2':3'-cyclic nucleotide phosphodiesterase:3'-nucleotidase and periplasmic 3':5'-CNP are distinct enzymes encoded by separate genes. With regard to cytoplasmic 3':5'-CNP (the cpdA gene product), the lack of hybridization of a 1.9-kb cpdP-based probe to sequences in the E. coli genome (see Materials and Methods) is consistent with cpdP and cpdA being distinct genes.
The cpdP promoter region lacks a canonical -35 hexanucleotide but contains adjacent to the site at which a -35 hexanucleotide would be expected a 12-bp inverted repeat that might serve as the binding site for a regulatory protein involved in activating cpdP transcription. If a transcriptional activator protein is involved, this protein probably is present in E. coli as well, since E. coli containing the V. fischeri cpdP gene expressed periplasmic 3':5'-CNP at levels similar to those in V. fischeri. We presently know very little about how the cpdP gene is regulated. Its expression might be influenced by the composition of the medium, since the specific activity of the enzyme is 2-to 10-fold higher for cells grown in minimal medium than in complete medium and since cells grown in minimal medium exhibit up to a 5-fold variation in specific activity, depending on the carbon and energy source (25) . No evidence for induction or repression of the enzyme, however, has been obtained. V. fischeni cells at different stages of growth in batch cultures exhibit similar 3':5'-CNP specific activities (22, 25) . Furthermore, cells grown on glucose in minimal medium exhibit no lag in growth when transferred to minimal medium containing cAMP as the sole carbon and energy source, whereas they do exhibit a 1-to 2-h lag when transferred to ribose (21) . These observations suggest that glucose does not repress the synthesis of 3':5'-CNP. In V. fischen, the regulatory region for the lu gene system contains a canonical cAMP receptor protein (CRP) binding site and a 20-bp inverted repeat that is thought to be the binding site for the LuxR protein, the transcriptional activator of the lux operon (see reference 36 for a review). In addition, cAMP controls the expression of the cpdB genes of E. coli and S. typhimurium and the D. discoideum extracellular 3':5'-CNP gene (31, 33) . The cpdP regulatory region, however, contains no sequences similar to the CRP or LuxR protein binding site. Consequently, it is likely that neither CRP nor the LuxR protein is involved in regulation of the cpdP gene. The apparent absence of glucose repression of the enzyme is consistent with the lack of a CRP binding site in the cpdP regulatory region.
The deduced amino acid sequence of the cpdP gene exhibited substantial identity with the low-affinity 3':5'-CNP (PDE1) of S. cerevisiae and the extracellular 3':5'-CNP ofD. discoideum (30.3 and 33.6%, respectively). The clustering of residue identities in two regions (residues 100 to 146 and residues 238 to 269 of the V. fischen sequence; Fig. 3 ) suggests that these regions may have functional importance for the enzyme. A hydropathy plot (30, 60) of the protein reveals that the region containing residues 100 to 146 is strongly hydrophilic, consistent with this region being able to interact with charged molecules, such as cAMP and cGMP. The two regions together contain 30 of the 33 residues conserved in all three proteins. Moreover, a single residue, histidine, accounts for 4 of the 30 residues conserved in all three proteins (3 in the first V. fischeri region and 1 in the second). Histidine represents only 2% of the residues in proteins of other prokaryotes (18) , and it is similarly uncommon in the V. fischen sequence (6 of 330 residues; Fig. 2 ). The scarcity of histidine residues is contrasted by their importance for catalysis in a recently described eukaryotic 3':5'-CNP (29) and by their involvement in the binding of metal ions, such as zinc, in metalloproteins (1, 15, 28) . With respect to metal ion binding by histidine, the presence of the chelating agent EDTA decreases the activity of the V. fischeri periplasmic 3':5'-CNP (25) . Also, the low-affinity 3':5'-CNP (PDE1) of S. cerevisiae contains two zinc atoms per peptide monomer (35) . For these reasons, we surmise that the two conserved regions contribute to the catalytic site, substrate binding, or conformation of the enzyme.
The similarity between the S. cerevisiae (PDE1) and D. discoideum 3':5'-CNP was noted previously by Nikawa et al. (40) , who proposed that these two proteins represent an evolutionary lineage distinct from other eukaryotic 3':5'-CNPs. In contrast to the S. cerevisiae (PDE1) and D. discoideum enzymes, all other eukaryotic 3':5'-CNPs share a conserved domain of 250 amino acid residues (15, 16, 40) .
The V. fischen enzyme lacks this domain. On the basis of the absence of this domain, the level of residue identity with the S. cerevisiae (PDE1) and D. discoideum enzymes, and other aspects discussed above, the V. fischeri 3':5'-CNP appears to be a member of the S. cerevisiae (PDE1) and D. discoideum lineage. The presence of a third member in this lineage, in this case a prokaryote, strengthens the proposal by Nikawa et al. (40) for two distinct lineages of 3':5'-CNPs.
The V. fischeri 3':5'-CNP permits cells to utilize 3':5'-cyclic nucleotides as growth substrates. The notion has been put forward (25) that the enzyme plays a role in species specificity of the bioluminescent symbiosis of V. fischeri with monocentrid fish and sepiolid squids (23, 43) . On the basis of this notion, cells of the developing animal light organ release cAMP in response to the presence of colonizing bacteria, and V. fischeri cells selectively colonize the light organ in the presence of other bacteria through the activity of the periplasmic 3' :5'-CNP, which protects V. fischeri cells from the toxic effects of host-released cAMP and permits them to utilize this compound as a growth substrate (25) . In the present study, however, we obtained no evidence supporting a role for the enzyme in defense against extracellular cAMP. MJ-301 (AcpdP::Nmr) growth and luminescence, which are controlled by cAMP, exhibited no obvious sensitivity to high extracellular levels of cAMP. Nonetheless, the enzyme could be important nutritionally in the symbiosis by permitting V. fischeri cells to inhibit by competition other bacteria unable to utilize cAMP. With the recent development of an experimental sepiolid squid symbiosis (43) and with the construction of a cpdP mutant of V. fischen, as described here, these issues can now be addressed experimentally. Alternatively, it is possible that the enzyme is involved in recovery of the carbon, nitrogen, and phosphorus released from the cell as cAMP, a process that could indicate that the synthesis and degradation of cAMP are separated into different cellular compartments in V. fischeri. Moreover, recent studies (22) indicate that certain other marine and terrestrial enteric bacteria produce a periplasmic 3':5'-CNP at levels similar to that in V. fischeri and that natural marine water samples contain substantial 3':5'-CNP activity (22) . A broad distribution of bacteria that possess periplasmic 3':5'-CNP suggests that the enzyme is an adaptation for scavenging 3':5'-cyclic nucleotides from the environment. Given its periplasmic location and exceptionally high specific activity (13), the V. fischeri 3':5'-CNP may be well suited to one or more of these functions.
